Evidence map›Paper›PMID 33065185›Full record

ArticleRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2021

COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2.

Barbara Alicja Jereczek-Fossa, Matteo Pepa, Mattia Zaffaroni, Giulia Marvaso, Alessio Bruni, Michela Buglione di Monale E Bastia, Gianpiero Catalano, Andrea Riccardo Filippi, Pierfrancesco Franco, Maria Antonietta Gambacorta and 18 more

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Managing unplanned radiotherapy interruptions in Italy: results from an AIRO survey.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  2. Article
  3. Preoperative accelerated hypofractionated radiotherapy (PHYPORT): state of art and potential clinical application.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2025
    Review
  4. Article
  5. Pattern of practice of re-irradiation for ipsilateral breast tumor recurrence in Italy: a survey by the Italian Association of Radiotherapy and Clinical Oncology (AIRO).Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors.

Barbara Alicja Jereczek-FossaDivision of Radiation Oncology, IEO, European Institute of Oncology, IRCCS, Milano, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milano, Italy.
Matteo PepaDivision of Radiation Oncology, IEO, European Institute of Oncology, IRCCS, Milano, Italy.
Mattia ZaffaroniDivision of Radiation Oncology, IEO, European Institute of Oncology, IRCCS, Milano, Italy. Electronic address: mattia.zaffaroni@ieo.it.
Giulia MarvasoDivision of Radiation Oncology, IEO, European Institute of Oncology, IRCCS, Milano, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milano, Italy.
Alessio BruniRadiotherapy Unit, Department of Oncology and Haematology, University Hospital of Modena, Italy.
Michela Buglione di Monale E BastiaDepartment of Radiation Oncology, University and Spedali Civili Hospital, Brescia, Italy.
Gianpiero CatalanoRadiation Oncology Centre, IRCCS Ospedale Multimedica, Sesto San Giovanni/Castellanza, Italy.
Andrea Riccardo FilippiDepartment of Radiation Oncology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Italy.
Pierfrancesco FrancoDepartment of Oncology, University of Turin, Torino, Italy.
Maria Antonietta GambacortaDepartment of Radiation Oncology, Università Cattolica del Sacro Cuore, Roma, Italy.
Domenico GenovesiRadiation Oncology Unit, "SS Annunziata" Hospital, "G. D'Annunzio" University, Chieti, Italy.
Giuseppe IatìRadiation Oncology Unit, Department of Biomedical, Dental Science and Morphological and Functional Images, University of Messina, Italy.
Alessandro MagliDepartment of Radiation Oncology, Udine General Hospital, Italy.
Luigi MarafiotiDivision of Radiotherapy, Azienda Ospedaliera di Cosenza, Italy.
Icro MeattiniRadiation Oncology Unit, Oncology Department, Azienda Ospedaliero Universitaria Careggi, Firenze, Italy; Department of Experimental and Clinical Biomedical Sciences "M. Serio", University of Florence, Firenze, Italy.
Anna MerlottiDepartment of Radiation Oncology, S. Croce and Carle Teaching Hospital, Cuneo, Italy.
Marcello MignognaRadiation Oncology Unit, S. Luca Hospital, Healthcare Company Tuscany Nord Ovest, Lucca, Italy.
Daniela MusioDepartment of Radiotherapy, Policlinico Umberto I "Sapienza" University of Rome, Roma, Italy.
Roberto PacelliDepartment of Advanced Biomedical Sciences, Federico II University, Napoli, Italy.
Stefano PergolizziRadiation Oncology Unit, Department of Biomedical, Dental Science and Morphological and Functional Images, University of Messina, Italy.
Vincenzo TomboliniDepartment of Radiotherapy, Policlinico Umberto I "Sapienza" University of Rome, Roma, Italy.
Marco TrovoDepartment of Radiation Oncology, Udine General Hospital, Italy.
Maria Cristina LeonardiDivision of Radiation Oncology, IEO, European Institute of Oncology, IRCCS, Milano, Italy.
Umberto RicardiDepartment of Oncology, University of Turin, Torino, Italy.
Stefano Maria MagriniDepartment of Radiation Oncology, University and Spedali Civili Hospital, Brescia, Italy.
Renzo CorvòDepartment of Radiation Oncology, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Health Science Department (DISSAL), University of Genoa, Genova, Italy.
Vittorio DonatoRadiation Oncology Division, Oncology and Specialty Medicine Department, San Camillo-Forlanini Hospital, Roma; President of AIRO (Italian Association of Radiotherapy and Clinical Oncology), Italy.
on the behalf of AIRO (Italian Association of Radiotherapy and Clinical Oncology)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19NeoplasmsDisease OutbreaksHumansItalyMedical OncologySARS-CoV-2Surveys and Questionnaires

Identifiers

PMID33065185
PMCPMC7553860

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.